FUNDC2, a mitochondrial outer membrane protein, mediates triple-negative breast cancer progression via the AKT/GSK3β/GLI1 pathway: FUNDC2 mediates TNBC progression via the AKT/GSK3β/GLI1 pathway

Triple-negative breast cancer (TNBC) lacks effective therapeutic targets and has a poor prognosis, easy recurrence and metastasis. It is urgent and important to explore TNBC treatment targets. Through mass spectrometry combined with qRT-PCR validation in luminal A cells and TNBC cells, high-content...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Liyang, Cao, Renxian, Liu, Zhuoqing, Luo, Gang, Li, Yu, Zhou, Xiaolong, Chen, Xiguang, Wu, Ying, He, Jun, Zu, Xuyu, Shen, Yingying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679879/
https://www.ncbi.nlm.nih.gov/pubmed/37700593
http://dx.doi.org/10.3724/abbs.2023142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679879/
https://www.ncbi.nlm.nih.gov/pubmed/37700593
http://dx.doi.org/10.3724/abbs.2023142

Ejemplares similares